NSC |
Compound |
Enrichment |
Correlation |
NSC 619688 |
Null |
0.0422011701988039 |
0.21330611 |
NSC 623520 |
Null |
0.0422011701988039 |
0.15196131 |
NSC 626108 |
Null |
0.0422011701988039 |
-0.12843112 |
NSC 658103 |
Null |
0.0422011701988039 |
0.51040435 |
NSC 659949 |
14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone |
0.0422011701988039 |
0.54088295 |
NSC 670313 |
Null |
0.0422011701988039 |
0.053426814 |
NSC 676914 |
2-(4-((4-amino-2-methylphenyl)diazenyl)phenylsulfonyl)ethanesulfonoperoxoic acid |
0.0422011701988039 |
0.20626927 |
NSC 678925 |
1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride |
0.0422011701988039 |
0.38253349 |
NSC 681636 |
Camptothecin Derivative |
0.0422011701988039 |
0.81750439 |
NSC 682011 |
Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- |
0.0422011701988039 |
0.20855492 |